ArticleCurrent research in food science2026
Dual inhibition of heterocyclic amines and advanced glycation end-products by polymethoxyflavones via trapping reactive intermediates and scavenging free radicals.
Article in Current research in food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymethoxyflavones (PMFs) are investigated for their inhibitory mechanisms against heterocyclic aromatic amines (HAs) and advanced glycation end products (AGEs). Tangeretin, isosinensetin (ISN), 3',4',5,7-tetramethoxyflavone (TMHF), and their mixture dose-dependently suppressed the formation of PhIP, CML, and CEL, with ISN and the mixture showing the strongest activity. PMFs also effectively scavenged free radicals and reduced key intermediates, including phenylacetaldehyde, glyoxal (GO), and methylglyoxal (MGO). UPLC-TOF-MS analysis revealed novel GO/MGO-PMF adducts, indicating that PMFs trap α-dicarbonyl compounds via covalent binding. In silico toxicity prediction suggested these adducts have lower mutagenic potential and chronic oral toxicity than PhIP, CML, and CEL. Collectively, PMFs inhibit HAs and AGEs through a dual mechanism of radical scavenging and reactive intermediate trapping, transforming hazardous precursors into less toxic products. These findings support PMFs as effective and safe natural inhibitors for mitigating process-induced contaminants in thermally processed foods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.